When treating CKD, angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) and sodium-glucose co-transporter-2 (SGLT-2) inhibitors are two commonly used drugs (88). Here, SLC5A2 is linked to chronic kidney disease.